Chemoinformaics analysis of Cis-P-Mentha-2,8-Dien-Ol
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -2.814 | nHRing | 0 |
| Solubility: LogP | 2.755 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.488 |
| Synth | 3.193 |
| Natural Product Likeliness | 1.513 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.003 |
| HIA | 0.007 |
| CACO-2 | -4.484 |
| MDCK | 0.0000221 |
| BBB | 0.84 |
| PPB | 0.814116 |
| VDSS | 0.799 |
| FU | 0.267348 |
| CYP1A2-inh | 0.708 |
| CYP1A2-sub | 0.905 |
| CYP2c19-inh | 0.482 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.576 |
| CYP2d6-inh | 0.153 |
| CYP2d6-sub | 0.467 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.35 |
| CL | 11.213 |
| T12 | 0.733 |
| hERG | 0.011 |
| Ames | 0.044 |
| ROA | 0.891 |
| SkinSen | 0.84 |
| Carcinogencity | 0.841 |
| EI | 0.956 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.91333 |